CRNX- Crinetics Pharmaceuticals, Inc.

Name: Crinetics Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Crinetics Pharmaceuticals, Inc. (CRNX) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. CRNX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Struthers Richard Scott	223.2K	$18.73M	-
Other	Betz Stephen F.	147.7K	$12.40M	-
COO	Knight Jeff E.	121.9K	$10.23M	-
CFO	Schilke Tobin	84.8K	$7.12M	-
Other	Pizzuti Dana	69.0K	$5.79M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 19, 2022	Krasner Alan Seth	Chief Medical Officer	Sale+OE	6,700	$21.21	$142,080.20	-44.6%	+13.5%	-6.6%
Jan 18, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	4,168	$23.29	$97,072.72	-3.1%	+6.4%	-12.8%
Jan 3, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	7,168	$28.02	$200,847.36	-5.1%	-12.9%	-36.1%
Dec 28, 2021	Betz Stephen F.61	Chief Scientific Officer	Sell	3,000	$27.95	$83,851.80	-2.1%	-29.4%	-36.2%
Dec 15, 2021	Betz Stephen F.61	Chief Scientific Officer	Sell	5,668	$24.14	$136,825.52	-3.8%	-24.2%	-35.5%
Dec 1, 2021	Betz Stephen F.61	Chief Scientific Officer	Sell	5,668	$27.38	$155,189.84	-3.7%	-21.3%	-29.3%
Nov 16, 2021	Betz Stephen F.61	Chief Scientific Officer	Sell	7,168	$27.01	$193,574.00	-2.3%	-33.1%	-34.0%
Nov 8, 2021	Betz Stephen F.61	Chief Scientific Officer	Sell	16,500	$28.06	$463,041.00	-4.8%	-35.4%	-36.3%
Nov 1, 2021	Fust Matthew K77	Director	Sale+OE	8,954	$25.50	$228,327.00	-41.7%	-29.9%	-31.3%
Nov 1, 2021	Betz Stephen F.61	Chief Scientific Officer	Sell	5,668	$24.79	$140,509.72	-3.1%	-29.9%	-31.3%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC